E-Pharma Market Trends & Forecast: The e-pharma market is projected to witness a compounded annual growth rate of 15.51%, growing to US$133.369 billion by 2030 from US$64.870 billion in 2025, according to a new report by Knowledge...
E-Pharma Market Trends & Forecast:
The e-pharma market is projected to witness a compounded annual growth rate of 15.51%, growing to US$133.369 billion by 2030 from US$64.870 billion in 2025, according to a new report by Knowledge Sourcing Intelligence. The rising technological advancement, such as blockchain, telemedicine, logistics and delivery innovations, AI, and e-commerce adoptions, is leading to the growth in the market. E-pharmacies offer patients the ability to order prescription and over-the-counter drugs online, which is contributing to its expansion. They also provide reminders of consultations, discounts, drug refill, and loyalty programs. These attributes lead to e-pharmacies witnessing growth in popularity in comparison to traditional pharmacies. Additionally, rising e-commerce adoption among consumers with a large number of people using online platform services for purchasing medications, offering convenience and transparency in pricing and availability of different brands. Government initiatives with policies and regulations for encouraging compliance and trust support the growth in the market. The growing investment and innovation, like the virtual catalog, prescription refills, integration of the automated platforms with medicine, and collaboration to provide quick delivery options and same-day delivery, is also leading to its growth during the forecasted period. ? View a sample of the report or purchase the complete study at: E-Pharma MarketE-Pharma Market Report Highlights:
- Over-the-counter (OTC) drugs segment is estimated to attain greater market share by 2030 in the drug type segment, driven by ease of purchase and availability on online platforms. this segment is witnessing a rise with the increase in the self-medication trends and growing requirement for non-prescription drugs. OTC drugs like cough, flu remedies, cold, dermatology products, vitamins, supplements, and minerals, among others, have widespread availability and demand as cost-effective self-medication.
- The dermatology segment is the major application segment in the market due to rising consumer awareness and growing demand for skincare products. E-pharma platform provides a wide range of skin products like sunscreen, acne treatment products, and anti-aging creams. It also provides availability to compare diverse brands with attractive discounts and offers with doorstep delivery. Changing trend in beauty standards and growing interest in preventive skincare is also leading to a rise in e-pharma platforms.
- North America held the largest market share, driven by the presence of prominent market players like Giant Eagle, Inc., Express Scripts Holding Company, and Canada Health Infoway. The rise in internet penetration, with growing adoption of e-prescription, is leading to growth in the market. The increasing integration of e-pharmacies with telemedicine services is witnessing growth in the region, with the presence of large retail pharmacies presences on the online platforms, further growing the market.
- Europe is anticipated to see major growth in the e-pharma market, due to the rise in internet penetration and the stringent regulatory environment in the region. The rising advanced technologies integration in the e-pharmacies, such as AI, digital tools, and machine learning, is also contributing to its rise in the region. The growing adoption of e-prescription with the European Cross-Border Electronic Prescription (CBeP) system makes it compulsory in countries like Germany and the UK, which provided a favourable environment for the growth of the e-pharma market.
E-Pharma Market Segmentation:
Knowledge Sourcing Intelligence has segmented the E-Pharma Market based on drug type, application, and region: E-Pharma Market, By Drug Type- Over-the-counter (OTC) drugs
- Prescription drugs
- Cold and flu
- Dental
- Dermatology
- Nutrition
- Weight management
- Others
- North America
- USA
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Others
- Asia Pacific
- Japan
- China
- India
- South Korea
- Indonesia
- Taiwan
- Thailand
- Others
- South America
- Brazil
- Argentina
- Others
- Middle East and Africa (MEA)
- Saudi Arabia
- UAE
- Others
E-Pharma Market Key Players:
- 1mg
- Canada Health Infoway
- Express Scripts Holding Company
- Giant Eagle, Inc.
- The Kroger Co.
- Netmeds Marketplace Ltd.
- OptumRx, Inc.
- Rowlands Pharmacy
- Walgreen Co.
- Amazon Pharmacy
Have questions?
More Press Releases
Lifestyle-Associated Cancer Epidemiology Market is expected to reach USD 13.12 billion by 2031
The worldwide market for lifestyle-associated cancer epidemiology is expected to expand rapidly, owing to the rising global awareness of modifiable risk factors such as tobacco use, obesity, poor diet, alcohol consumption, and physical inactivity, which together contribute significantly to cancer incidence. Health organizations, along with research institutions, are investing in enhanced surveillance, behavioral risk monitoring, cancer registries, and prevention strategies to address the growing burden of preventable cancers. In recent years, the World Health Organization and several national bodies have emphasized data-driven epidemiology. These initiatives support targeted interventions, policy measures, and screening programs. Additionally, the widespread adoption of digital epidemiology tools, precision prevention approaches, and AI-powered analytics is fueling the demand for robust epidemiology infrastructure worldwide.
Psycho-Oncology Digital Health Market is anticipated to surpass USD 290.01 million in 2031 at a CAGR of 8.5%
The psycho-oncology digital health market is expanding as healthcare providers increasingly integrate digital mental health solutions into cancer care. Growing demand for AI-driven platforms, digital cognitive behavioral therapy, telehealth, and mobile applications is improving access to psychological support. North America leads the market, while Asia Pacific is expected to witness the fastest growth.
Intratumoral Injection Therapy Market is expected to reach USD 630.39 million by 2031
The worldwide market for Intratumoral Injection Therapy is expected to experience substantial growth in the market due to the increasing demand for localized cancer treatments that are essential in enhancing therapeutic efficacy while also minimizing systemic toxicity. Intramural injection therapy is often involved with direct administration of therapeutic agents into tumors, which enables high local drug concentrations and targets immune activation. Growing interest in gene therapies, cancer immunotherapy, and on-politic viruses, including cytokine-based therapies are also accelerating market expansion.